BNP treatment for recovery from septic shock
Part of Heart & circulation, Infections clinical trials.
This trial tests if a heart medication called recombinant human brain natriuretic peptide (BNP) can help people who are recovering from septic shock. It may improve heart function and reduce the need for other medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You are recovering from septic shock and need less medication to keep your blood pressure stable.
- You have signs of heart strain or damage, like a high BNP or NT-proBNP level, or a low heart pumping ability (ejection fraction below 50%).
- You have not had a dose of water pills (diuretics) in the last 6 hours.
- You have a normal heart rhythm (sinus rhythm) and a small tube in your artery to monitor heart function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a protein called rhBNP (which helps the heart relax) to standard care after a heart attack and stent improves heart recovery and pumping strength over time.
This study tests a non-invasive, goal-based treatment approach for people with septic shock—an emergency condition caused by severe infection. It may help by using blood-pressure and circulation targets to guide care without more invasive procedures.
This trial studies how norepinephrine affects the heart and circulation in adults with septic shock whose blood pressure stays low after the first day. It may help doctors better choose and adjust medicines to support blood pressure and organ function.
This trial examines how the renin-angiotensin-aldosterone system (a hormone system that helps control blood pressure) changes in patients with septic shock, compared to those with sepsis without shock, cardiogenic shock, and healthy volunteers. The goal is to better understand these changes and possibly improve treatment.
This trial tests whether checking a blood marker called NT-proBNP at your bedside while in the hospital helps doctors better manage acute heart failure. It could lead to more personalized treatment and a clearer picture of your recovery.
This Phase 3 trial tests whether starting a medicine called norepinephrine early can improve outcomes for adults with sepsis (a serious body-wide response to infection) and low blood pressure. You might be considered if you’re very early in hospital care and meet specific blood pressure and lactate tests.
Hear when a new Sepsis Induced Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.